Cost-Effectiveness Analysis of the Optimal Control Strategies for Multidrug-Resistant Tuberculosis Transmission in Ethiopia

被引:0
|
作者
Mengistu, Ashenafi Kelemu [1 ]
Witbooi, Peter J. [1 ]
机构
[1] Univ Western Cape, Dept Math & Appl Math, Private Bag X17, ZA-7535 Bellville, South Africa
关键词
D O I
10.1155/2023/8822433
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
Despite the recent progress of global control efforts, tuberculosis (TB) remains a significant public health threat worldwide, especially in developing countries, including Ethiopia. Furthermore, the emergence of multidrug-resistant tuberculosis (MDR-TB) has further complicated the situation. This study aims at identifying the most effective strategies for combating MDR-TB in Ethiopia. We first present a compartmental model of MDR-TB transmission dynamics in Ethiopia. The model is shown to have positive solutions, and the stability of the equilibrium points is analyzed. Then, we extend the model by incorporating time-dependent control variables. These control variables are vaccination, distancing, and treatment for DS-TB and MDR-TB. Finally, the optimality system is numerically simulated by considering different combinations of the strategies, and their cost effectiveness is analysed. Our finding shows that, among single control strategies, the successful treatment of drug-susceptible tuberculosis (DS-TB) is the most effective control factor for eliminating MDR-TB transmission in Ethiopia. Furthermore, within the six dual control strategies, the combination of distancing and successful treatment of DS-TB is less costly and more effective than other strategies. Finally, out of the triple control strategies, the combination of distancing, successful treatment for DS-TB, and treatment for MDR-TB is the most efficient strategy for curbing the MDR-TB disease in Ethiopia. Thus, to reduce MDR-TB efficiently, it is recommended that authorities focus on treating MDR-TB, effective treatment of DS-TB, and promoting social distancing through public health education and awareness programs.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Cost-effectiveness of treating multidrug-resistant tuberculosis
    Resch, Stephen C.
    Salomon, Joshua A.
    Murray, Megan
    Weinstein, Milton C.
    PLOS MEDICINE, 2006, 3 (07) : 1048 - 1057
  • [2] Tuberculosis in Ethiopia: Optimal Intervention Strategies and Cost-Effectiveness Analysis
    Mengistu, Ashenafi Kelemu
    Witbooi, Peter J.
    AXIOMS, 2022, 11 (07)
  • [3] SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL: A COST-EFFECTIVENESS ANALYSIS
    Macedo, E.
    Macedo, K. C. A.
    Castro, J. D.
    Silva, L. F.
    VALUE IN HEALTH, 2020, 23 : S176 - S176
  • [4] Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia
    Floyd, Katherine
    Hutubessy, Raymond
    Kliiman, Kai
    Centis, Rosella
    Khurieva, Nina
    Jakobowiak, Wieslaw
    Danilovits, Manfred
    Peremitin, Genadi
    Keshavjee, Salmaan
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (01) : 133 - 142
  • [5] Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts A Cost-Effectiveness Analysis
    Fox, Gregory J.
    Oxlade, Olivia
    Menzies, Dick
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (02) : 229 - 237
  • [6] Cost-effectiveness of Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the Republic of Korea
    Park, Hae-Young
    Ku, Hye-min
    Sohn, Hyun-Soon
    Seo, Hae-Sook
    Lee, Hyun Yung
    Lim, Kyung Hwa
    Kwon, Jin-Won
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 655 - 667
  • [7] Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: A cohort study in the Philippines
    Tupasi, Thelma E.
    Gupta, Rajesh
    Quelapio, Ma Imelda D.
    Orillaza, Ruth B.
    Mira, Nona Rachel
    Mangubat, Nellie V.
    Belen, Virgil
    Arnisto, Nida
    Macalintal, Lualhati
    Arabit, Michael
    Lagahid, Jaime Y.
    Espinal, Marcos
    Floyd, Katherine
    PLOS MEDICINE, 2006, 3 (09) : 1587 - 1596
  • [8] COST EFFECTIVENESS OF BEDAQUILINE FOR THE TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS
    Wolfson, L.
    Walker, A.
    Hettle, R.
    Lu, X.
    Kambili, C.
    Murungi, A.
    Knerer, G.
    VALUE IN HEALTH, 2014, 17 (07) : A595 - A595
  • [9] The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
    Weerasuriya, Chathika K.
    Harris, Rebecca C.
    McQuaid, C. Finn
    Bozzani, Fiammetta
    Ruan, Yunzhou
    Li, Renzhong
    Li, Tao
    Rade, Kirankumar
    Rao, Raghuram
    Ginsberg, Ann M.
    Gomez, Gabriela B.
    White, Richard G.
    BMC MEDICINE, 2021, 19 (01)
  • [10] The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
    Chathika K Weerasuriya
    Rebecca C Harris
    C Finn McQuaid
    Fiammetta Bozzani
    Yunzhou Ruan
    Renzhong Li
    Tao Li
    Kirankumar Rade
    Raghuram Rao
    Ann M Ginsberg
    Gabriela B Gomez
    Richard G White
    BMC Medicine, 19